BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 28017631)

  • 1. Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis.
    Mahfood Haddad T; Hamdeh S; Kanmanthareddy A; Alla VM
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S209-S216. PubMed ID: 28017631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.
    Targher G; Byrne CD; Lonardo A; Zoppini G; Barbui C
    J Hepatol; 2016 Sep; 65(3):589-600. PubMed ID: 27212244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.
    Mantovani A; Csermely A; Petracca G; Beatrice G; Corey KE; Simon TG; Byrne CD; Targher G
    Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):903-913. PubMed ID: 34555346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis.
    Wu S; Wu F; Ding Y; Hou J; Bi J; Zhang Z
    Sci Rep; 2016 Sep; 6():33386. PubMed ID: 27633274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis.
    Jaruvongvanich V; Wirunsawanya K; Sanguankeo A; Upala S
    Dig Liver Dis; 2016 Dec; 48(12):1410-1417. PubMed ID: 27697419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
    Mantovani A; Zaza G; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.
    Mantovani A; Dauriz M; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Oct; 87():1-12. PubMed ID: 29935236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease.
    Brea Á; Pintó X; Ascaso JF; Blasco M; Díaz Á; González-Santos P; Hernández-Mijares A; Mantilla T; Millán J; Pedro-Botet J;
    Clin Investig Arterioscler; 2017; 29(4):185-200. PubMed ID: 27692632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coffee consumption is not associated with prevalent subclinical cardiovascular disease (CVD) or the risk of CVD events, in nonalcoholic fatty liver disease: results from the multi-ethnic study of atherosclerosis.
    Simon TG; Trejo MEP; Zeb I; Frazier-Wood AC; McClelland RL; Chung RT; Budoff MJ
    Metabolism; 2017 Oct; 75():1-5. PubMed ID: 28964324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease.
    Brea Á; Pintó X; Ascaso JF; Blasco M; Díaz Á; González-Santos P; Hernández Mijares A; Mantilla T; Millán J; Pedro-Botet J;
    Clin Investig Arterioscler; 2017; 29(3):141-148. PubMed ID: 27692633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: A systematic review and meta-analysis.
    Wijarnpreecha K; Lou S; Panjawatanan P; Cheungpasitporn W; Pungpapong S; Lukens FJ; Ungprasert P
    Dig Liver Dis; 2018 Nov; 50(11):1166-1175. PubMed ID: 30292566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis.
    Arulanandan A; Ang B; Bettencourt R; Hooker J; Behling C; Lin GY; Valasek MA; Ix JH; Schnabl B; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1513-20.e1. PubMed ID: 25661453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease as a predictor of atrial fibrillation: a systematic review and meta-analysis.
    Zhou Y; Lai C; Peng C; Chen M; Li B; Wang X; Sun J; Sun C
    Postepy Kardiol Interwencyjnej; 2017; 13(3):250-257. PubMed ID: 29056998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis.
    Upala S; Jaruvongvanich V; Wijarnpreecha K; Sanguankeo A
    J Bone Miner Metab; 2017 Nov; 35(6):685-693. PubMed ID: 27928661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis.
    Mantovani A; Turino T; Altomari A; Lonardo A; Zoppini G; Valenti L; Tilg H; Byrne CD; Targher G
    Metabolism; 2019 Jul; 96():56-65. PubMed ID: 31047909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
    Piazza NA; Singal AK
    Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Mantovani A; Nascimbeni F; Lonardo A; Zoppini G; Bonora E; Mantzoros CS; Targher G
    Thyroid; 2018 Oct; 28(10):1270-1284. PubMed ID: 30084737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis.
    Zhou YY; Zhou XD; Wu SJ; Hu XQ; Tang B; Poucke SV; Pan XY; Wu WJ; Gu XM; Fu SW; Zheng MH
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):631-636. PubMed ID: 29351115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between nonalcoholic fatty liver disease and atrial fibrillation and other clinical outcomes: a meta-analysis.
    Jaiswal V; Ang SP; Huang H; Momi NK; Hameed M; Naz S; Batra N; Ishak A; Doshi N; Gera A; Sharath M; Waleed MS; Raj N; Aguilera Alvarez VH
    J Investig Med; 2023 Aug; 71(6):591-602. PubMed ID: 37002665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.